Immunome Inc. (IMNM) stock
IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$16.78−0.40 (-2.33%)
Close on Nov 18, 2026Market cap $1.91BP/E –Yield –
Immunome market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Immunome's market cap was $2.16B on Nov 11, 2026, against $1.69B a year earlier. Over the last 5 years it ranged from $26.80M to $3.10B, with a median of $641.68M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.16B | +9.6% |
| 2025 | Dec 31, 2025 | $1.97B | +207.0% |
| 2024 | Dec 31, 2024 | $641.68M | +391.5% |
| 2023 | Dec 29, 2023 | $130.57M | +387.2% |
| 2022 | Dec 30, 2022 | $26.80M | -82.9% |
| 2021 | Dec 31, 2021 | $156.73M | +1339.7% |
| 2020 | Dec 31, 2020 | $10.89M | – |
See a number that looks wrong?